Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Dabrafenib Mesylate 1195768-06-9,Dabrafenib Mesylate CAS 1195768-06-9,Dabrafenib Mesylate CAS NO 1195768-06-9
Conbott Pharmtech Co.,Ltd. Dabrafenib Mesylate 1195768-06-9,Dabrafenib Mesylate CAS 1195768-06-9,Dabrafenib Mesylate CAS NO 1195768-06-9
Home > Products > Inhibitors > BRAF Inhibitors > High Quality Dabrafenib Mesylate, 1195768-06-9
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit
High Quality Dabrafenib Mesylate, 1195768-06-9

High Quality Dabrafenib Mesylate, 1195768-06-9

Share to:  
    Payment Type: T/T,L/C
    Delivery Time: 7 Days

Basic Info

Model No.: 1195768-06-9

Additional Info

Packaging: AS Required

Productivity: Customized


Transportation: Ocean,Air

Place of Origin: CHINA

Supply Ability: Commercial


Product Description

1195768-06-9,High Quality Dabrafenib Mesylate

We have rich experience in making dabrafenib mesylate Cas 1195768-06-9 Dabrafenib Mesylate manufacturers and suppliers in China. These high quality products are formulated by adopting quality methods and using well-tested ingredients that are procured from the certified vendors of the market. We offer these products in proper packaging of diverse quantity to meet assorted requirements of the clients.

Thera. Category: Anti- cancer

Cas No.: 1195768-06-9

Synonym: Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);GSK 2118436 methanesulfonate salt

Molecular Formula:C24H24F3N5O5S3

1195768-06-9 Dabrafenib

Molecular Weight: 615.6680696

Assay: ≥97.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.

Related Intermediates :
1. CAS 630-22-8,2,2,2-Trimethylthioacetamide

Looking for ideal Dabrafenib Mesylate 1195768-06-9 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Dabrafenib Mesylate CAS 1195768-06-9 are quality guaranteed. We are China Origin Factory of Dabrafenib Mesylate CAS NO 1195768-06-9. If you have any question, please feel free to contact us.

Product Categories : Inhibitors > BRAF Inhibitors

Product Images
  • High Quality Dabrafenib Mesylate, 1195768-06-9
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2020 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?